Semax Positively Potentiates AMPA Receptors

Semax Positively Potentiates AMPA Receptors

This post was originally published on this site

AMPA Positive Modulators have cognition- and memory-enhancing and antidepressant-like effects in preclinical models, and have potential medical applications in the treatment of cognitive impairment (e.g., cognitive symptoms in schizophrenia, mild cognitive impairment), dementia (e.g., Alzheimer’s disease), depression, and for other indications.

(That includes Aniracetam,Pramiracetam, Piracetam, Oxiracetam, IDRA-21, Sunifiram/Unifiram, and so on)

Subscribe, Like And Share!

Leave a Reply